Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Incyte Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
INCY
Nasdaq
2834
www.incyte.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Incyte Corporation
Incyte to Present at Upcoming Investor Conferences
- Feb 17th, 2026 6:00 am
The Top 5 Analyst Questions From Incyte’s Q4 Earnings Call
- Feb 16th, 2026 10:32 pm
Is It Too Late To Consider Incyte (INCY) After Its 43% One Year Rally
- Feb 12th, 2026 3:13 pm
Do Wall Street Analysts Like Incyte Corporation Stock?
- Feb 12th, 2026 1:24 am
Company News for Feb 11, 2026
- Feb 11th, 2026 7:29 am
INCY Q4 Deep Dive: Revenue Growth Outpaces Profit as Pipeline Advances, Margins Narrow
- Feb 10th, 2026 10:32 pm
Incyte Crumbles As Light Opzelura Guide Undoes Quarterly Sales Beat
- Feb 10th, 2026 2:08 pm
Incyte Q4 Earnings Call Highlights
- Feb 10th, 2026 1:50 pm
Incyte Corp (INCY) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Pipeline ...
- Feb 10th, 2026 12:03 pm
Incyte Corporation Q4 2025 Earnings Call Summary
- Feb 10th, 2026 10:31 am
Why Incyte (INCY) Stock Is Nosediving
- Feb 10th, 2026 10:05 am
INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales
- Feb 10th, 2026 8:38 am
Incyte (INCY) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
- Feb 10th, 2026 7:30 am
Incyte (INCY) Q4 Earnings Lag Estimates
- Feb 10th, 2026 6:15 am
Incyte (NASDAQ:INCY) Surprises With Q4 CY2025 Sales
- Feb 10th, 2026 5:35 am
Incyte: Q4 Earnings Snapshot
- Feb 10th, 2026 5:24 am
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results
- Feb 10th, 2026 5:00 am
Incyte (INCY) Q4 Earnings: What To Expect
- Feb 8th, 2026 8:07 pm
Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards?
- Feb 6th, 2026 6:23 am
Assessing Incyte (INCY) Valuation After CHMP Backing For Zynyz In Anal Canal Cancer
- Feb 6th, 2026 3:05 am
Scroll